BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34652551)

  • 1. Short-duration dynamic [
    Yang DM; Alfano R; Bauman G; Thiessen JD; Chin J; Pautler S; Moussa M; Gomez JA; Rachinsky I; Gaed M; Chung KJ; Ward A; Lee TY
    EJNMMI Res; 2021 Oct; 11(1):107. PubMed ID: 34652551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [
    Yang DM; Li F; Bauman G; Chin J; Pautler S; Moussa M; Rachinsky I; Valliant J; Lee TY
    EJNMMI Res; 2021 Jan; 11(1):2. PubMed ID: 33394284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Bauman G; Martin P; Thiessen JD; Taylor R; Moussa M; Gaed M; Rachinsky I; Kassam Z; Chin J; Pautler S; Lee TY; Valliant JF; Ward A
    Eur Urol Focus; 2018 Sep; 4(5):702-706. PubMed ID: 28753797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts.
    Goodman CD; Fakir H; Pautler S; Chin J; Bauman GS
    Adv Radiat Oncol; 2020; 5(2):212-220. PubMed ID: 32280821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic validation of auto-contoured dominant intraprostatic lesions on [
    Alfano R; Bauman GS; Liu W; Thiessen JD; Rachinsky I; Pavlosky W; Butler J; Gaed M; Moussa M; Gomez JA; Chin JL; Pautler S; Ward AD
    Radiother Oncol; 2020 Nov; 152():34-41. PubMed ID: 32827589
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wondergem M; van der Zant FM; Knol RJJ; Lazarenko SV; Pruim J; de Jong IJ
    J Nucl Med; 2017 Nov; 58(11):1797-1804. PubMed ID: 28450569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY
    Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
    Turkbey B; Mena E; Shih J; Pinto PA; Merino MJ; Lindenberg ML; Bernardo M; McKinney YL; Adler S; Owenius R; Choyke PL; Kurdziel KA
    Radiology; 2014 Mar; 270(3):849-56. PubMed ID: 24475804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pilot Study of Dynamic
    Lu M; Lindenberg L; Mena E; Turkbey B; Seidel J; Ton A; McKinney Y; Eclarinal P; Merino M; Pinto P; Choyke P; Adler S
    Mol Imaging Biol; 2022 Jun; 24(3):444-452. PubMed ID: 34724140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Evaluation of
    Song H; Harrison C; Duan H; Guja K; Hatami N; Franc BL; Moradi F; Aparici CM; Davidzon GA; Iagaru A
    J Nucl Med; 2020 Apr; 61(4):546-551. PubMed ID: 31628216
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplified Methods for Quantification of
    Jansen BHE; Yaqub M; Voortman J; Cysouw MCF; Windhorst AD; Schuit RC; Kramer GM; van den Eertwegh AJM; Schwarte LA; Hendrikse NH; Vis AN; van Moorselaar RJA; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2019 Dec; 60(12):1730-1735. PubMed ID: 31000583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric and Voxel-Wise Analysis of Dominant Intraprostatic Lesions on Multiparametric MRI.
    Lee J; Carver E; Feldman A; Pantelic MV; Elshaikh M; Wen N
    Front Oncol; 2019; 9():616. PubMed ID: 31334128
    [No Abstract]   [Full Text] [Related]  

  • 14. Early lesion detection with
    Wondergem M; Jansen BHE; van der Zant FM; van der Sluis TM; Knol RJJ; van Kalmthout LWM; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1911-1918. PubMed ID: 31230088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Glicksman RM; Metser U; Valliant J; Chung PW; Fleshner NE; Bristow RG; Green D; Finelli A; Hamilton R; Stanescu T; Hussey D; Catton C; Gospodarowicz M; Warde P; Bayley A; Breen S; Vines D; Jaffray DA; Berlin A
    BMJ Open; 2020 Apr; 10(4):e035959. PubMed ID: 32327479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate and dominant intraprostatic lesion segmentation on PET/CT using cascaded regional-net.
    Matkovic LA; Wang T; Lei Y; Akin-Akintayo OO; Abiodun Ojo OA; Akintayo AA; Roper J; Bradley JD; Liu T; Schuster DM; Yang X
    Phys Med Biol; 2021 Dec; 66(24):. PubMed ID: 34808603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using
    Floberg JM; Wells SA; Ojala D; Bayliss RA; Hill PM; Morris BA; Morris ZS; Ritter M; Cho SY
    Adv Radiat Oncol; 2023; 8(5):101241. PubMed ID: 37250282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraindividual Comparison of
    Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M
    J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSMA-based
    Zhang X; Son MH; Ha LN; Lan X
    Am J Nucl Med Mol Imaging; 2022; 12(6):195-200. PubMed ID: 36636231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
    Rowe SP; Gorin MA; Hammers HJ; Som Javadi M; Hawasli H; Szabo Z; Cho SY; Pomper MG; Allaf ME
    Ann Nucl Med; 2015 Dec; 29(10):877-82. PubMed ID: 26286635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.